Dutch-based IGM Resins, a developer and supplier of products and technical services to the global radcure industry, has acquired the photoinitiator business of Lamberti. The acquisition adds to IGM’s technical development capabilities and brings an advantaged product line that includes materials compliant with US FDA and stringent European regulatory requirements, and which are complementary to the company’s extensive photoinitiator offerings. IGM Resins is a portfolio company of Arsenal Capital Partners. The acquisition includes all assets, technology, intellectual property and employees dedicated to the R&D and commercial activities related to the business, which will be operated as a division of IGM near Milan, Italy, in a new office laboratory complex. Products include the ESACURE line, which will continue to be sold under the existing brand. The manufacturing unit, which includes IGM-owned assets, and pilot plant will continue to be operated by Lamberti under a manufacturing agreement. “We are excited to have the Lamberti team join IGM and expand our already broad range of specialty and all-purpose photoinitiators with the ESACURE brand products,” said Edward Frindt, CEO of IGM Resins. “This acquisition, along with the recent addition of IHT in August 2014, further moves IGM into the forefront of developing next-generation safe and easy-to-use photoinitiators for UV inks, coatings and specialty markets. It also increases our ability to expand capacity and sales to a growing market.” Added John Huiberts, president of IGM Resins, “The addition of the ESACURE photoinitiators enhances our extensive product line and will better position IGM to meet the changing UV requirements and higher demands of the market. It will enable us to offer a larger range of high performance specialty photoinitiators and enhanced technical service to our customers.” www.igmresins.com